Fidelity Investments’s Lisata Therapeutics LSTA Stock Holding History

Fidelity Investments’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1	Closed	-$3	–	5431
2023 Q2	$4	Hold	1	–	–	﹤0.01%	5323
2023 Q1	$3	Hold	1	–	–	﹤0.01%	5229
2022 Q4	$2	Hold	1	–	–	﹤0.01%	5317
2022 Q3	$0	Buy	+1	New	+$7	﹤0.01%	5200
2021 Q1	–	Hold	0	–	–	–	4311
2020 Q4	–	Hold	0	–	–	–	4109
2020 Q2	–	Sell	-27	Closed	-$1K	–	3936
2020 Q1	$1K	Buy	+27	New	+$1.05K	﹤0.01%	3503

Other funds holding LSTA

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments's LSTA Position: Q3 2023 in Review

Fidelity Investments sold out of Lisata Therapeutics (LSTA) in Q3 2023, closing a stake of 1 share — an estimated $3 sold.

Fidelity Investments first reported a position in LSTA in Q1 2020 and held it in 5 quarters. The position peaked at $1K in Q1 2020. 21 funds tracked by Wall St. Rank hold LSTA as of Q3 2023.

Fidelity Investments reported no remaining Lisata Therapeutics position as of Q3 2023 after selling out during the quarter.
Fidelity Investments sold 1 Lisata Therapeutics share in Q3 2023, an estimated $3.
Fidelity Investments first reported a position in Lisata Therapeutics in Q1 2020 and held it in 5 quarters.
Fidelity Investments's Lisata Therapeutics position peaked at $1K in Q1 2020.
21 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2023.

Based on Fidelity Investments's 13F filing for Q3 2023, filed 13 Nov 2023.